This was recently evident in Wilms' tumour for which an additional marker (ALDH) within the NCAM1+ fraction was used to more precisely pinpoint cancer stem/initiating cells in the tumour (Pode-Shakked et al, 2013). This evidence concerns the gene NCAM1 and Wilms tumor.